Literature DB >> 33846906

Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review.

Chang-Yu Hsieh1, Tsen-Fang Tsai2.   

Abstract

H-1 antihistamines are commonly used in dermatological practice for itch and urticaria control. The widespread expression of H-1 receptor on different cells in the skin and various biologic functions of H-1 antihistamines indicate the possible treatment potentials of H-1 antihistamines in dermatology. A literature search was performed on PubMed and Embase, targeting articles reporting use of antihistamine for purposes other than itch and urticaria control in dermatological practice. Several off-label usages of antihistamines were identified, including alopecia, acne, Darier disease, eosinophilic dermatoses, paraneoplastic dermatoses, psoriasis, lichen nitidus, radiation dermatitis, skin dysesthesia, and cutaneous malignancies. Additional benefits were observed when H-1 antihistamines were used either alone or in combination with other therapeutic modalities. Although various novel uses of H-1 antihistamines have been uncovered, the evidence level of most included studies is weak. Further randomized control trials are warranted to better evaluate the efficacy and dosage of H-1 antihistamine for dermatological disorders.

Entities:  

Keywords:  Anti-inflammation; Dermatology; H-1 antihistamines; Off-label usages; Pleiotropic effects

Year:  2021        PMID: 33846906     DOI: 10.1007/s13555-021-00524-w

Source DB:  PubMed          Journal:  Dermatol Ther (Heidelb)


  69 in total

Review 1.  Non-H1-receptor effects of antihistamines.

Authors:  M K Church
Journal:  Clin Exp Allergy       Date:  1999-07       Impact factor: 5.018

2.  Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5.

Authors:  Annapina Russo; Giulia Russo; Manuela Peticca; Concetta Pietropaolo; Massimo Di Rosa; Teresa Iuvone
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  The effect of mizolastine on expression of vascular endothelial cell growth factor, tumour necrosis factor-alpha and keratinocyte-derived chemokine in murine mast cells, compared with dexamethasone and loratadine.

Authors:  Q Xia; S Yang; S Q Zhang; B Chen; D B Wang; Q X Zhu; Y Wang; K L Yan; P P He; X J Zhang
Journal:  Clin Exp Dermatol       Date:  2005-03       Impact factor: 3.470

4.  Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated rats.

Authors:  Ilya D Ionov; Nicholas P Gorev; Larissa A Roslavtseva; David D Frenkel
Journal:  Anticancer Drugs       Date:  2018-11       Impact factor: 2.248

5.  Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.

Authors:  Sidharth Chopra; Karen Matsuyama; Christopher Hutson; Peter Madrid
Journal:  J Antimicrob Chemother       Date:  2011-04-11       Impact factor: 5.790

6.  The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar, and keloid.

Authors:  B M Topol; V L Lewis; K Benveniste
Journal:  Plast Reconstr Surg       Date:  1981-08       Impact factor: 4.730

7.  The role of histamine in the regulation of the viability, proliferation and transforming growth factor β1 secretion of rat wound fibroblasts.

Authors:  Monika Wolak; Ewa Bojanowska; Teresa Staszewska; Joanna Ciosek; Marlena Juszczak; Jacek Drobnik
Journal:  Pharmacol Rep       Date:  2016-11-15       Impact factor: 3.024

8.  The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts.

Authors:  H Suzawa; S Kikuchi; N Arai; A Koda
Journal:  Jpn J Pharmacol       Date:  1992-10

9.  Emedastine difumarate inhibits histamine-induced collagen synthesis in dermal fibroblasts.

Authors:  H Murota; S Bae; Y Hamasaki; R Maruyama; I Katayama
Journal:  J Investig Allergol Clin Immunol       Date:  2008       Impact factor: 4.333

10.  In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates.

Authors:  Moustafa A El-Nakeeb; Hamida M Abou-Shleib; Amal M Khalil; Hoda G Omar; Omar M El-Halfawy
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

View more
  2 in total

1.  An IFI6-based hydrogel promotes the healing of radiation-induced skin injury through regulation of the HSF1 activity.

Authors:  Jie Hao; Mengyi Sun; Dong Li; Tao Zhang; Jianjun Li; Daijun Zhou
Journal:  J Nanobiotechnology       Date:  2022-06-18       Impact factor: 9.429

2.  Multifunctional mesoporous silica-cerium oxide nanozymes facilitate miR129 delivery for high-quality healing of radiation-induced skin injury.

Authors:  Min Du; Han Luo; Daijun Zhou; Fengwei Ran; Xiang Zhao; Yan Dong; Tao Zhang; Jie Hao; Dong Li; Jianjun Li
Journal:  J Nanobiotechnology       Date:  2022-09-14       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.